The protein kinase activity modulation sites: Mechanisms for cellular regulation - Targets for therapeutic intervention

被引:32
作者
Engh, RA
Bossemeyer, D [1 ]
机构
[1] DKFZ, German Canc Res Ctr, Res Program Tumor Cell Regulat, Dept Pathochem, D-69120 Heidelberg, Germany
[2] Max Planck Inst Biochem, D-82152 Martinsried, Germany
[3] Roche Diagnost GmbH, Pharma Res Penzberg, Penzberg, Germany
来源
ADVANCES IN ENZYME REGULATION, VOL 41 | 2001年 / 41卷
关键词
D O I
10.1016/S0065-2571(00)00010-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein kinases catalyze the phosphoryl transfer reaction fundamental to most signaling and regulatory processes in the eukaryotic cell. The signaling reaction is covalent transfer of the gamma phosphoryl group of ATP, and in exceptional cases GTP, to threonine, serine, or tyrosine residues of the substrate protein. Each member of the huge protein kinase family has its individual cellular function and role; many or most phosphorylate more than one substrate protein. Thus, absolute control of individual protein kinase activity is of utmost importance to the cell. How this modulation, including complete but reversible inactivation, can be achieved has been shown by crystal structures of many active and inactive protein kinases. This article presents a survey of inactivated kinase structures, compared with the structures of active and catalytically competent kinases, such as protein kinase A catalytic subunit (PKAc) which demonstrates the repetitive occurrence of structural alterations in certain regions of the catalytic kinase core. These sites or elements, classified here as "activity modulation sites," comprise four structures: the activation segment with its continuation into the P + 1 region, helix C, the glycine rich flap, and the ATP-binding pocket. We address the question of whether these constitute the primary evolved mechanisms for modulation of enzyme activity in the catalytic domain, and thus represent the mechanisms operative for most other protein kinases and physiological regulators, and how this might impact strategies for discovery and design of therapeutic drugs.
引用
收藏
页码:121 / 149
页数:29
相关论文
共 74 条
[1]   PHOSPHORYLATION MODULATES CATALYTIC FUNCTION AND REGULATION IN THE CAMP-DEPENDENT PROTEIN-KINASE [J].
ADAMS, JA ;
MCGLONE, ML ;
GIBSON, R ;
TAYLOR, SS .
BIOCHEMISTRY, 1995, 34 (08) :2447-2454
[2]   The structure of phosphorylated P38γ is monomeric and reveals a conserved activation-loop conformation [J].
Bellon, S ;
Fitzgibbon, MJ ;
Fox, T ;
Hsiao, HM ;
Wilson, KP .
STRUCTURE, 1999, 7 (09) :1057-1065
[3]   PHOSPHOTRANSFERASE AND SUBSTRATE BINDING MECHANISM OF THE CAMP-DEPENDENT PROTEIN-KINASE CATALYTIC SUBUNIT FROM PORCINE HEART AS DEDUCED FROM THE 2.0 ANGSTROM STRUCTURE OF THE COMPLEX WITH MN2+ ADENYLYL IMIDODIPHOSPHATE AND INHIBITOR PEPTIDE PKI(5-24) [J].
BOSSEMEYER, D ;
ENGH, RA ;
KINZEL, V ;
PONSTINGL, H ;
HUBER, R .
EMBO JOURNAL, 1993, 12 (03) :849-859
[4]   THE GLYCINE-RICH SEQUENCE OF PROTEIN-KINASES - A MULTIFUNCTIONAL ELEMENT [J].
BOSSEMEYER, D .
TRENDS IN BIOCHEMICAL SCIENCES, 1994, 19 (05) :201-205
[5]   Crystal structure and mutational analysis the human CDK2 kinase complex with cell cycle-regulatory protein CksHs1 [J].
Bourne, Y ;
Watson, MH ;
Hickey, MJ ;
Holmes, W ;
Rocque, W ;
Reed, SI ;
Tainer, JA .
CELL, 1996, 84 (06) :863-874
[6]   Crystal structure of the complex of the cyclin D dependent kinase Cdk6 bound to the cell-cycle inhibitor p19INK4d [J].
Brotherton, DH ;
Dhanaraj, V ;
Wick, S ;
Brizuela, L ;
Domaille, PJ ;
Volyanik, E ;
Xu, X ;
Parisini, E ;
Smith, BO ;
Archer, SJ ;
Serrano, M ;
Brenner, SL ;
Blundell, TL ;
Laue, ED .
NATURE, 1998, 395 (6699) :244-250
[7]   The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases [J].
Brown, NR ;
Noble, MEM ;
Endicott, JA ;
Johnson, LN .
NATURE CELL BIOLOGY, 1999, 1 (07) :438-443
[8]   Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity [J].
Brown, NR ;
Noble, MEM ;
Lawrie, AM ;
Morris, MC ;
Tunnah, P ;
Divita, G ;
Johnson, LN ;
Endicott, JA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (13) :8746-8756
[9]   FREQUENT SOMATIC MUTATIONS AND HOMOZYGOUS DELETIONS OF THE P16 (MTS1) GENE IN PANCREATIC ADENOCARCINOMA [J].
CALDAS, C ;
HAHN, SA ;
DACOSTA, LT ;
REDSTON, MS ;
SCHUTTE, M ;
SEYMOUR, AB ;
WEINSTEIN, CL ;
HRUBAN, RH ;
YEO, CJ ;
KERN, SE .
NATURE GENETICS, 1994, 8 (01) :27-32
[10]   Activation mechanism of the MAP kinase ERK2 by dual phosphorylation [J].
Canagarajah, BJ ;
Khokhlatchev, A ;
Cobb, MH ;
Goldsmith, EJ .
CELL, 1997, 90 (05) :859-869